Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FCYHR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $103,555
Award facts
- Contract value 100% obligated
- $103,555.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $103.6K delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens under a firm fixed price contract on July 8, 2025, with completion scheduled for July 9, 2025. This competitive award carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Health Agency and military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its comprehensive IDC vehicle to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to federal customers. Cosentyx, a biologic immunosuppressant used in dermatology and rheumatology treatments, represents part of the contractor's extensive portfolio of specialty medications distributed through the DLA's Medical Supply Chain. The DLA Troop Support Medical contract structure enables flexible fulfillment of critical pharmaceutical requirements to support military personnel and veteran healthcare globally, with the agency planning future generation contracts potentially involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FCYHR?
SPE2DB25FCYHR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 8, 2025.
How much is contract SPE2DB25FCYHR worth?
The government has obligated $103,555 on SPE2DB25FCYHR.
Is contract SPE2DB25FCYHR an order under another contract?
Yes. SPE2DB25FCYHR is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYHR competed?
The extent of competition for SPE2DB25FCYHR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award